White Paper One · Clinical Evidence
A plain-language review of a 2025 JAMA Network Open study comparing fixed and escalating shock energy in out-of-hospital cardiac arrest.
When an AED delivers a shock, it follows an energy sequence programmed into the device. Some AEDs deliver the same energy for every shock (a fixed regimen). Others increase the energy with each shock that follows (an escalating regimen).
A 2025 cohort study published in JAMA Network Open compared these two approaches in adults who experienced out-of-hospital cardiac arrest with ventricular fibrillation (VF). Both regimens stopped VF at the first shock in most cases. But the escalating higher-energy regimen was more likely to keep VF from returning and to restore an organized heart rhythm, particularly in patients who needed several shocks.
The first shock worked about equally well in both groups. The difference appeared afterward, in whether the heart stayed out of ventricular fibrillation.
Ventricular fibrillation is a chaotic heart rhythm that stops the heart from pumping blood. The study notes that VF is the initial rhythm in up to 40% of out-of-hospital cardiac arrests, and that survival is far more likely when VF is treated with rapid, effective defibrillation than when the heart is in asystole or pulseless electrical activity.
Defibrillation is not always a single event. In many cardiac arrests, VF stops after a shock and then returns. Some patients remain in VF after several shocks, a condition called refractory VF.
According to the study authors, the 2020 American Heart Association guidelines and the 2021 European Resuscitation Council guidelines support increasing shock energy when a shock fails or VF recurs, but more clinical evidence on the benefit of higher energy has been needed.
All AEDs in the study came from the same model series and had their energy sequence programmed before the study began. Each AED delivered one of two regimens:
200 J → 300 J → 360 J
Used for 218 patients (480 VF episodes).
200 J → 200 J → 200 J
Used for 124 patients (302 VF episodes).
The regimen each patient received depended only on which AED was available, and rescuers did not know which regimen the device used.
Escalating vs. Fixed Energy: What the Study Found
VF briefly stopped by the first shock (both groups at 200 J)
No meaningful difference
VF still stopped at the next rhythm analysis
No meaningful difference
Sustained organized rhythm established (all shocks)
Statistically significant difference
Organized rhythm after the second shock and above (refractory VF)
Statistically significant difference
Organized rhythm after the third shock and above (refractory VF)
Statistically significant difference
Source: Tang H, et al. JAMA Network Open. 2025;8(4):e257411.
At the first shock, both groups received 200 J. VF was briefly terminated in 94% of cases in the escalating group and 93% in the fixed group, with no significant difference.
Only about half of those VF episodes remained terminated until the next rhythm analysis (49% vs 47%). The authors observed that most patients with refractory VF were not resistant to shocks. Their hearts left VF after a shock but could not stay out of it.
Across all shocks, VF treated with the escalating regimen was more likely to convert to a sustained organized rhythm (34% vs 25%).
In patients who needed repeated shocks, the escalating regimen established an organized rhythm more often after the second shock and above (24% vs 13%) and after the third shock and above (35% vs 18%).
The authors concluded that when a first shock at conventional energy fails, defibrillation with more energy is a better choice, and that escalating regimens might be preferred for patients with shockable rhythms.
The authors identified several limitations, and they matter when interpreting these results:
The authors call for larger prospective studies. The findings add to earlier research, including a 2005 randomized trial cited in the paper, that also favored escalating higher energy in patients with refractory VF.
AED owners do not choose shock energy during a rescue. The AED follows the sequence its manufacturer and configuration determine. That is exactly why this research is relevant to how an AED program is managed.
Different AED models deliver different energy sequences. Understanding the energy capability of each device in your deployment, as documented by its manufacturer, belongs in any informed AED program review, particularly when you are planning replacements or expanding to new locations.
Any change to an AED’s configuration should follow the manufacturer’s instructions and your program’s medical direction. Research findings like these are a reason to ask informed questions, not to alter equipment.
Manufacturers sometimes release updates affecting shock sequences, CPR prompts or operating software. Confirming that applicable updates have been completed is part of keeping an AED aligned with current manufacturer guidance.
Every shock in an escalating sequence requires the battery to charge the device’s high-voltage circuitry again, and every shock depends on electrode pads that make proper contact with the patient. Expired pads, aging batteries and unresolved recalls can undermine the device regardless of its energy design.
Shock energy research only matters if the AED on your wall is ready to deliver every shock in its sequence.
AED Service America’s nationwide onsite AED maintenance and program management help organizations keep every device aligned with manufacturer requirements:
Have a question about the AEDs in your deployment? Our team can help you review what you have and what the manufacturer requires.
Tang H, Wu R, Yin L, Hao W, Shi J, Zhu H, Xu S, Xu J. Escalating vs Fixed Energy Defibrillation in Out-of-Hospital Cardiac Arrest Ventricular Fibrillation. JAMA Network Open. 2025;8(4):e257411. doi:10.1001/jamanetworkopen.2025.7411
Read the full open-access study: PubMed Central (PMC12042058). The original article is published under a CC-BY license.
This white paper is an independent plain-language summary prepared by AED Service America for educational purposes. It is not medical advice, and it is not affiliated with or endorsed by the study authors or the journal. Consult your AED manufacturer and medical director regarding device configuration.
Let AED Service America review your AEDs against manufacturer requirements, from pads and batteries to recalls and protocol updates.
Phone: 860-970-3250
Email: support@aedserviceamerica.com